US Patent Issued to Galimedix Therapeutics on Aug. 11 for "Crystalline forms of solvates of tryptophan derivatives, compositions comprising them and uses thereof" (Hungarian, Swiss, German Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,685, issued on Aug. 11, was assigned to Galimedix Therapeutics Inc..

"Crystalline forms of solvates of tryptophan derivatives, compositions comprising them and uses thereof" was invented by Jozsef Repasi (Erd, Hungary), Andras Szabo (Budapest, Hungary), Hermann Kurt Russ (Altendorf, Switzerland) and Markus Henrich (Munzenberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides crystalline forms of solvates of tryptophan derivatives of compound (1), compositions comprising them, processes for their preparations and methods of use thereof."

The patent was filed on May 23, 2021, under Application No. 17/992,961.

*For furthe...